GSK3B and breast cancer: Also, p70S6K can phosphorylate and inactivate GSK-3β, which, in turn, is responsible for p70S6K activation [40], and GSK-3β is considered a key regulatory molecule in the sensitivity of breast cancer cells to chemo-, hormonal, and targeted therapy [59].